Back to search
Cervical Cancer by FIGO Stage 2018
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cervical Cancer by FIGO Stage 2018 trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cervical Cancer by FIGO Stage 2018 trials you may qualify forThis phase III trial compares the addition of induction chemotherapy, with carboplatin, paclitaxel and pembrolizumab, to chemotherapy and radiation, with cispla…
Cervical cancer is the fourth most common cancer in women worldwide, with approximately 604,000 new cases in 2020.Treatment for locally advanced cervical cancer…
This is a single-arm, prospective, multi-center clinical trial designed to demonstrate that adaptive radiotherapy for locally advanced cervical cancer will tran…
This phase II trial studies how well time-restricted eating works in reducing side effects of radiation or chemoradiation side effects when compared to nutritio…
This study will include patients with invasive cervical cancer that wish to keep their fertility as much as possible in the future after treatment. Patients wh…
This is a Phase II study of neoadjuvant therapy of AK104 combined with nab-paclitaxel/carboplatin in fertility saving surgery for stage IB2-IB3 cervical cancer…
Cervical cancer is the fourth most common cancer among women and is mainly linked to infection with high-risk human papillomaviruses (HPV). Although most HPV in…
The goal of this clinical trial is to learn if the combination of Pembrolizumab and Lenvatinib works to treat locally advanced cervical cancer in adults that wi…
This study collects blood samples to determine if the DNA of HPV that causes cervical cancer can be detected in patients with cervical cancer that is new (prima…